Breast Screening
Find information on Breast Screening, also known as Mammogram Screening or Breast Cancer Screening. This resource provides details relevant to healthcare professionals, including clinical documentation and medical coding for Breast Screening procedures. Learn about diagnosis codes, billing guidelines, and best practices for documenting mammograms and other breast imaging studies. Improve your clinical documentation and ensure accurate coding for Breast Screening.
Regular x-ray examination of breasts to detect early signs of breast cancer, often before symptoms appear.
Usually asymptomatic. Later signs may include a new lump, skin changes, nipple discharge.
Outpatient radiology clinics, mobile mammography units, hospitals, breast centers.
ICD-10 Code Families
Complete code families applicable to Z12.31
When to use each related code
| Description | When to use |
|---|---|
| Screening for breast cancer in asymptomatic women. | Routine screening, typically for women over 50. Use for preventative checks and early detection. |
| Evaluation of a palpable breast lump or other breast symptom. | Patient presents with breast lump, nipple discharge, skin changes, or other breast concerns. Not for routine screening. |
| Follow-up imaging for previously detected breast abnormality. | Use for monitoring known breast changes, post-biopsy, or after abnormal mammogram/ultrasound findings. |
Best-practice checklist
- ✓Patient demographics, medical history
- ✓Date and type of mammogram (screening/diagnostic)
- ✓Breast density (ACR BI-RADS classification)
- ✓Relevant clinical findings, palpable masses
- ✓Assessment, recommendations, follow-up plan
Common pitfalls to avoid
Missing or incorrect laterality (right, left, bilateral) for breast screening can lead to claim denials and inaccurate reporting.
Miscoding screening mammograms as diagnostic mammograms based on patient history or symptoms can result in overpayment and compliance issues. Important for accurate medical coding and CDI.
Incorrectly billing separate codes for components of a breast screening exam that should be bundled can lead to rejected claims and healthcare fraud allegations.
Best-practice tips
- 01Ensure accurate laterality documentation (right, left, bilateral) for ICD-10-CM coding.
- 02Document breast density (ACR BI-RADS) for Z12.31 compliance and risk assessment.
- 03Code screening mammograms with Z12.31, diagnostic mammograms with specific ICD-10-CM codes.
- 04Record family history of breast cancer and BRCA status for improved risk stratification.
- 05For abnormal findings, link to follow-up diagnostic imaging and biopsy results in documentation.
Step-by-step checklist
- 1
Verify patient age and risk factors (ICD-10 Z12.31)
- 2
Confirm recent mammogram not performed (SNOMED CT 709043000)
- 3
Assess breast density for tailored screening (BI-RADS)
- 4
Document patient consent and shared decision-making
Ready-to-paste narrative
Patient presented for routine breast cancer screening mammogram. Patient reports no current breast complaints, such as breast pain, nipple discharge, or skin changes. No palpable breast lumps are noted on self-breast exam. Family history is significant for maternal aunt diagnosed with breast cancer at age 60. Patient's menarche was at age 12, and she is nulliparous. She denies use of hormone replacement therapy. Mammogram imaging was performed today, including bilateral craniocaudal and mediolateral oblique views. Assessment of mammogram images revealed no suspicious masses, calcifications, or architectural distortions. BIRADS classification is assigned as 1 (negative). Patient was counseled on breast self-examination and the importance of regular breast cancer screenings. Recommended next screening mammogram in one year. Diagnosis: Routine mammographic screening. ICD-10 code: Z12.31. CPT code: 77057.
Common questions and answers
What are the current best practice guidelines for breast density assessment during mammogram screening and how can I integrate them into my practice?+
Breast density is a significant factor in both breast cancer risk and mammographic sensitivity. Current best practice guidelines, including those from the American College of Radiology (ACR) and the Society of Breast Imaging (SBI), recommend informing women about their breast density and its implications. Specifically, women with dense breast tissue should be counseled about the potential for masking of cancers on mammography and the benefits and limitations of supplemental screening modalities like ultrasound or MRI. To integrate these guidelines, consider implementing a standardized reporting system that includes breast density assessment in every mammogram report. Explore how automated breast density software can assist in consistent and objective assessments, improving workflow efficiency and patient communication. Learn more about risk-based screening strategies that incorporate breast density and other risk factors for personalized patient management.
How can I effectively communicate the limitations of mammography screening for breast cancer with patients, especially those with dense breast tissue?+
Effectively communicating the limitations of mammography requires clear and empathetic patient communication. Begin by explaining that mammography, while a valuable tool, isn't perfect. It can miss some cancers (false negative) and sometimes identify areas that look suspicious but turn out to be benign (false positive). For women with dense breasts, emphasize that the dense tissue can make it harder to detect small cancers on mammograms. Use visual aids to illustrate this concept. Clearly explain the potential benefits and limitations of supplemental screening options, such as ultrasound and MRI, without creating undue anxiety. Consider implementing decision aids to help patients make informed choices based on their individual risk factors and preferences. Explore how shared decision-making tools can facilitate these conversations and improve patient satisfaction.
What are the latest advancements in breast cancer screening technologies beyond traditional mammography, and what are the considerations for their implementation in a clinical setting?+
Beyond traditional 2D mammography, advancements like 3D mammography (tomosynthesis), contrast-enhanced mammography (CEM), and automated breast ultrasound (ABUS) offer improved cancer detection, particularly in women with dense breasts. Molecular breast imaging (MBI) is also emerging as a promising technique. When considering implementation, evaluate the clinical evidence supporting each technology, including its sensitivity, specificity, and impact on patient outcomes. Assess the cost-effectiveness of each modality, considering factors like equipment purchase, maintenance, and personnel training. Consider patient comfort and tolerance during the procedure, as well as the availability of trained radiologists and technologists. Learn more about integrating these technologies into existing workflows and developing appropriate referral pathways to ensure optimal patient care.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.